RBC Capital Markets cut the target to $110 from $122. Maintains sector perform rating
https://www.marketscreener.com/quote/stock/NEUROCRINE-BIOSCIENCES-I-10163/
RBC Capital Markets cut the target to $110 from $122. Maintains sector perform rating
https://www.marketscreener.com/quote/stock/NEUROCRINE-BIOSCIENCES-I-10163/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.